Mitochondria-Targeted Compound Library
Ref. TM-L5300
1mg | To inquire | |
30µl*10 (DMSO) | To inquire | |
50µl*10 (DMSO) | To inquire | |
100µl*10 (DMSO) | To inquire | |
250µl*10 (DMSO) | To inquire |
Product Information
A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;
- Targets include mitochondria related targets, such as ATPase, mitochondria-associated hexokinase, Bcl-2, NADP, etc. and inhibitors for the autophagy initiating factor, ULK1, also include other promising mitochondria-targeted compounds such as lonidamine, paclitaxel, etc;
- Bioactivity and safety confirmed by pre-clinical research and clinical trials;
- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;
- Structurally diverse, medicinally active, and cell permeable;
- NMR and HPLC validated to ensure high purity and quality;
Chemical properties
Technical inquiry about: TM-L5300 Mitochondria-Targeted Compound Library
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.